Clinical Trials Directory

Trials / Sponsors / ALX Oncology Inc.

ALX Oncology Inc.

Industry · 9 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positiv
Breast Cancer, Metastatic
Phase 22025-12-10
RecruitingA First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC, CRC (Colorectal Cancer)
Phase 12025-08-18
CompletedA Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)
Bladder Cancer, Urothelial Carcinoma
Phase 12022-11-02
Active Not RecruitingA Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
Phase 2 / Phase 32022-01-15
Active Not RecruitingEvorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Phase 22021-05-10
TerminatedA Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)
Acute Myeloid Leukemia, AML, Adult
Phase 12021-05-05
Active Not RecruitingEvorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Ca
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Phase 22021-04-02
TerminatedA Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02)
Higher Risk Myelodysplastic Syndromes
Phase 12020-10-02
CompletedA Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
Metastatic Cancer, Solid Tumor, Advanced Cancer
Phase 12017-02-03